Increased appetite Some people experience increased hunger when using ipamorelin
Standard TB-500 protocol: Loading phase (Weeks 1-4): 5mg twice weekly (Monday/Thursday) Total per week: 10mg Total for loading: 40mg (8 vials of 5mg) Maintenance phase (Weeks 5-12): 2-5mg once weekly Total per week: 2-5mg Total for maintenance: 16-40mg (3-8 vials) Example: 5mg vial + 2ml water = 2,500mcg/ml 5mg dose (5,000mcg) = draw 2.0ml (full vial) 2.5mg dose = draw 1.0ml TB-500 doses are MUCH larger than BPC-157
It is not inherently one or the other, but rather a potent hormone that must be carefully balanced
These products meet the allowable health claims and labeling requirements of the Food and Drug Administration (FDA), and theyre manufactured in facilities that adhere to current good manufacturing practices (CGMPs)
Poor fat distribution often translates to increased cholesterol and hypertension
Ipamorelin: synthetic pentapeptide PEPTIDE SEQUENCE CJC-1295 (no DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH 2 CHEMICAL STRUCTURE CJC-1295: Ipamorelin: CHEMICAL STRUCTURE CJC-1295 (no DAC): C 152 H 252 N 44 O 42 Ipamorelin: C 38 H 49 N 9 O 5 Mechanism of Action The CJC-1295 (no DAC) + ipamorelin peptide blend stimulates endogenous growth hormone (GH) release by simultaneously activating the growth hormone-releasing hormone receptor (GHRH-R) and the ghrelin/growth hormone secretagogue receptor (GHSR), resulting in synergistic, physiologically pulsatile GH secretion
